Currently, Kairos Pharma Ltd’s (KAPA) stock is trading at $1.76, marking a gain of 81.44% from last night’s close. At this price, the stock is -56.00% below its 52-week high of $4.00 and 106.82% above its 52-week low of $0.85. Based on the past 30-day period, the stock price is -30.00% below the high and +101.53% above the low.
KAPA’s price to book ratio for the most recent quarter was 6.79, resulting in an 7.02 price to cash per share for the period.
How does Kairos Pharma Ltd (KAPA) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
Kairos Pharma Ltd (AMEX: KAPA) Ownership Details
I will give a breakdown of the key shareholders in Kairos Pharma Ltd (KAPA). Recent figures show that the company’s insiders hold 68.83% of shares. A total of 1 institutional investors hold shares in the company, making 0.10% of its stock and 0.32% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is Virtu Financial LLC holding total of 32.71 shares that make 0.25% of the company’s total number of shares and are currently priced at 66449.0.
The securities firm HRT Financial LP holds 12.61 shares of KAPA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.10%, and the holding percentage of shares is valued at 25613.0.
An overview of Kairos Pharma Ltd’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Kairos Pharma Ltd (KAPA) traded 1,879,664 shares per day, with a moving average of $1.5688 and price change of +0.0550. With the moving average of $1.5573 and a price change of +0.3750, about 1,069,508 shares changed hands on average over the past 50 days.
